Lactiplantibacillus plantarum ATG-K2 프로바이오틱스(제2025-58호)
Lactiplantibacillus plantarum ATG-K2 프로바이오틱스(제2025-58호)
MFDS recognition no.
제2025-58호
Approval route
Individually approved (개별인정형) — only the approval holder may use this wording
Daily intake (as approved)
4000000000.0–4000000000.0 CFU/일
Approved wording (Korean original)
(국문) 체지방 감소에 도움을 줄 수 있음
(영문) May help to reduce body fat
Precautions (Korean original)
(1) 영·유아, 어린이, 임산부 및 수유부는 섭취를 피할 것
(2) 특정질환(알레르기 체질, 단장증후군 등)이 있는 분은 섭취에 주의할 것
(3) 이상사례 발생 시 섭취를 중단하고 전문가와 상담할 것
(4) 과다 섭취하지 말 것
the FDA, EFSA or your national authorityRequirements differ by market. Confirm ingredient status and label wording with your own authority before importing.
Approvals described here were issued by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and are valid in South Korea only. They are not health claims in your jurisdiction and have not been evaluated by the FDA, EFSA, or any other authority. This page reports regulatory facts and does not recommend any product.